What were FDC Ltd's latest quarterly results?
FDC Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -24.3%
- Revenue Growth YoY: +0.2%
- Operating Margin: 11.0%
FDC Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 22.5. ROE: 11.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
FDC Ltd's latest quarterly results (Dec 2025) show
FDC Ltd's current PE ratio is 22.5x.
FDC Ltd's price-to-book ratio is 2.1x.
FDC Ltd's fundamental strength based on key financial ratios
FDC Ltd has a debt-to-equity ratio of N/A.
FDC Ltd's return ratios over recent years
FDC Ltd's operating cash flow is positive (FY2025).
FDC Ltd's current dividend yield is 1.56%.
FDC Ltd's shareholding pattern (Dec 2025)
FDC Ltd's promoter holding has remained stable recently.
FDC Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why FDC Ltd may be worth studying
FDC Ltd investment thesis summary:
FDC Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.